Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearSign Technologies (CLIR) Total Liabilities (2016 - 2025)

Historic Total Liabilities for ClearSign Technologies (CLIR) over the last 12 years, with Q3 2025 value amounting to $3.7 million.

  • ClearSign Technologies' Total Liabilities rose 6155.88% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year increase of 6155.88%. This contributed to the annual value of $2.2 million for FY2024, which is 1136.74% down from last year.
  • Per ClearSign Technologies' latest filing, its Total Liabilities stood at $3.7 million for Q3 2025, which was up 6155.88% from $3.8 million recorded in Q2 2025.
  • ClearSign Technologies' 5-year Total Liabilities high stood at $3.8 million for Q2 2025, and its period low was $1.1 million during Q3 2022.
  • Over the past 5 years, ClearSign Technologies' median Total Liabilities value was $1.9 million (recorded in 2024), while the average stood at $2.1 million.
  • In the last 5 years, ClearSign Technologies' Total Liabilities soared by 18603.56% in 2023 and then plummeted by 4015.43% in 2024.
  • ClearSign Technologies' Total Liabilities (Quarter) stood at $1.1 million in 2021, then rose by 27.01% to $1.4 million in 2022, then skyrocketed by 76.84% to $2.4 million in 2023, then decreased by 11.37% to $2.2 million in 2024, then skyrocketed by 70.49% to $3.7 million in 2025.
  • Its Total Liabilities stands at $3.7 million for Q3 2025, versus $3.8 million for Q2 2025 and $2.5 million for Q1 2025.